EYESW (Second Sight Medical Products) Pretax Margin %: % (As of Jun. 2022)


What is Second Sight Medical Products Pretax Margin %?

Second Sight Medical Products EYESW Pretax Margin % is % as of Jun. 2022. The stock has 1 warning sign investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Second Sight Medical Products's Pre-Tax Income for the three months ended in Jun. 2022 was $-3.08 Mil. Second Sight Medical Products's Revenue for the three months ended in Jun. 2022 was $0.00 Mil. Therefore, Second Sight Medical Products's pretax margin for the quarter that ended in Jun. 2022 was %.

The historical rank and industry rank for Second Sight Medical Products's Pretax Margin % or its related term are showing as below:


EYESW's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.4
* Ranked among companies with meaningful Pretax Margin % only.

Second Sight Medical Products  (NAS:EYESW) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Second Sight Medical Products Pretax Margin % Related Terms


Second Sight Medical Products Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Second Sight Medical Products's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Second Sight Medical Products Pretax Margin % Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -358.06 -508.90 -994.14 0.00 0.00

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EYESW vs SONX, LUCD, LHDX: Pretax Margin % Comparison

For the Medical Devices subindustry, Second Sight Medical Products's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Second Sight Medical Products Pretax Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's Pretax Margin % falls into.



Second Sight Medical Products Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Second Sight Medical Products's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-8.921/0
= %

Second Sight Medical Products's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-3.076/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Second Sight Medical Products (EYESW) has a Pretax Margin % of % as of Jun. 2022. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Second Sight Medical Products and its competitors.
Is Second Sight Medical Products' Pretax Margin % too high?
Second Sight Medical Products' current Pretax Margin % is %.
How does Second Sight Medical Products' Pretax Margin % compare to SONX and LUCD?
Second Sight Medical Products' Pretax Margin % of % can be compared against companies in the Medical Devices & Instruments industry. The industry median Pretax Margin % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Second Sight Medical Products and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Second Sight Medical Products's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current Pretax Margin % is % as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Second Sight Medical Products Business Description

Address 13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.